You are here: Home » Current Affairs » News » National
Business Standard

Rare case of post-dengue mucormycosis reported in Delhi: Doctors

A "rare" case of mucormycosis has been reported in a 49-year-old male patient at a leading private hospital here post his recovery from dengue, doctors said on Saturday.

Topics
Dengue | Dengue cases

Press Trust of India  |  New Delhi 

A government health worker collects blood sample from a patient at a dengue detention centre in Kolkata. Photo: Reuters
Representative Image

A "rare" case of mucormycosis has been reported in a 49-year-old male patient at a leading private hospital here post his recovery from dengue, doctors said on Saturday.

The case reported at the Apollo hospital in south Delhi comes amid a huge spike in the number of cases in the capital.

According to a civic report on vector-borne diseases released on Monday, nine deaths and a total of 2,708 cases have been recorded this season till November 6, which is the highest count since 2017 for the same period.

Over 1,170 cases were logged in the first week of November.

In a statement issued on Saturday, the Apollo hospital said, "A 49-year-old male has been reported to be one the rare cases of post-mucormycosis by a team of doctors at the hospital."

The patient had come to the hospital, complaining about a sudden loss of vision in one eye, 15 days after his recovery from the vector-borne disease.

During the second wave of the COVID-19 pandemic earlier this year, a large number of cases of the "black fungus" were reported throughout the country after the coronavirus infection was detected in patients suffering with chronic diabetes.

Mucormycosis or the "black fungus" is more common among people whose immunity has got lowered due to COVID-19, diabetes, kidney disease, liver or cardiac disorders, age-related issues or those on medication for auto-immune diseases like rheumatoid arthritis.

Mucormycosis post dengue is a new observation and hence, patients with a recent history of dengue should remain actively updated about their health and consult a healthcare expert immediately after noticing any new symptoms, doctors at the Apollo hospital said.

Dr Suresh Singh Naruka, senior consultant (ENT), Indraprastha Apollo Hospitals, who is leading the treatment of the patient, said, "A rare case of black fungus (mucormycosis) came into our view when the patient came to the hospital, reporting a sudden loss of vision in one eye post dengue fever. It is rarest of the rare to see mucormycosis as a post-recovery complication in a dengue patient as this condition is generally seen in people who have a history of diabetes, compromised immunity and various other infections."


"It is a deadly infection caused by a group of fungus called mucor. This fungus invades into the healthy tissues of the nose, sinuses, eyes and brain so rapidly that any delay in diagnosis and management can lead to adverse long-term complications," he added.

Dengue is accompanied with high fever and therefore, doctors feel that people might suspect that they have contracted COVID-19.

The dengue mosquito larvae breed in clear, standing water, while those of malaria thrive even in dirty water.

Dr Atul Ahuja, senior consultant (ENT and head and neck surgery) at the hospital, said, "Diagnosing and managing a case of rhino-orbital (involving nose and eye) mucormycosis in a patient who has just recovered from dengue fever is very important, as even after best treatment, patients of mucormycosis can lose their eyesight permanently and in a state of an aggressive infection, removal of eye becomes necessary for preventing any further spread of infection."

Dr Nishant Rana, registrar at the facility, said, "Before coming to the hospital, the patient had an episode of nasal bleeding as a complication owing to dengue 15 days prior to his recovery, wherein he noted a low count of platelets with no transfusion history. Mucormycosis in his case is a resultant factor of compromised immunity owing to dengue.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, November 13 2021. 17:27 IST
RECOMMENDED FOR YOU
.